Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| COMMONWEALTH BIOTECHNOLOGIES INC | 754,839 | reported | 22 Dec 2020 | tx 18+4,371,734−1,047,000 |
| Lipocine Inc. | 11,526 | reported | 04 Jun 2025 | tx 19+196,778−2,625 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 04 Jun 2025 | GRANT_AWARD | Lipocine Inc. | 1,764 | 3.20 USD | deriv |
| 05 Jun 2024 | GRANT_AWARD | Lipocine Inc. | 1,764 | 7.05 USD | deriv |
| 10 May 2023 | GRANT_AWARD | Lipocine Inc. | 30,000 | 0.27 USD | deriv |
| 20 Mar 2023 | PURCHASE | Lipocine Inc. | 4,000 | 0.34 USD | first after silence |
| 08 Jun 2022 | GRANT_AWARD | Lipocine Inc. | 22,000 | 0.92 USD | deriv |
| 09 Jun 2021 | GRANT_AWARD | Lipocine Inc. | 22,000 | 1.26 USD | deriv |
| 22 Dec 2020 | GRANT_AWARD | COMMONWEALTH BIOTECHNOLOGIES INC | 754,839 | 0.00 USD | deriv |
| 16 Dec 2020 | EXERCISE | Lipocine Inc. | 5,250 | 0.00 USD | |
| 16 Dec 2020 | EXERCISE | Lipocine Inc. | 5,250 | 0.00 USD | deriv |
| 10 Jun 2020 | GRANT_AWARD | Lipocine Inc. | 22,000 | 0.96 USD | deriv |
| 20 Mar 2020 | GRANT_AWARD | COMMONWEALTH BIOTECHNOLOGIES INC | 1,000,000 | 0.00 USD | deriv |
| 12 Jun 2019 | GRANT_AWARD | Lipocine Inc. | 10,000 | 1.68 USD | deriv |
| 03 Feb 2019 | GRANT_AWARD | COMMONWEALTH BIOTECHNOLOGIES INC | 657,895 | 0.00 USD | deriv |
| 27 Jun 2018 | GRANT_AWARD | Lipocine Inc. | 20,000 | 1.33 USD | deriv |
| 13 Mar 2018 | GRANT_AWARD | COMMONWEALTH BIOTECHNOLOGIES INC | 253,000 | 0.00 USD | deriv |
| 13 Mar 2018 | GRANT_AWARD | COMMONWEALTH BIOTECHNOLOGIES INC | 56,000 | 0.00 USD | deriv |
| 29 Dec 2017 | EXERCISE | Lipocine Inc. | 1,750 | 0.00 USD | |
| 29 Dec 2017 | SALE | Lipocine Inc. | 875 | 3.47 USD | |
| 29 Dec 2017 | EXERCISE | Lipocine Inc. | 1,750 | 0.00 USD | deriv |
| 08 Mar 2017 | TAX_WITHHOLDING | COMMONWEALTH BIOTECHNOLOGIES INC | 118,800 | 0.34 USD | |
| 08 Mar 2017 | TAX_WITHHOLDING | COMMONWEALTH BIOTECHNOLOGIES INC | 59,400 | 0.34 USD | |
| 08 Mar 2017 | EXERCISE | COMMONWEALTH BIOTECHNOLOGIES INC | 150,000 | — | |
| 08 Mar 2017 | EXERCISE | COMMONWEALTH BIOTECHNOLOGIES INC | 300,000 | — | |
| 08 Mar 2017 | TAX_WITHHOLDING | COMMONWEALTH BIOTECHNOLOGIES INC | 118,800 | 0.34 USD | |
| 08 Mar 2017 | EXERCISE | COMMONWEALTH BIOTECHNOLOGIES INC | 300,000 | — |
1 purchase reported after at least 12 months of silence — most recent on 20 Mar 2023.